Table of Content

1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 32
1.2.2 MARKETS COVERED 33
FIGURE 1 HEARING AIDS MARKET SEGMENTATION 33
1.2.3 YEARS CONSIDERED FOR THE STUDY 33
1.3 CURRENCY 34
1.4 LIMITATIONS 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.2 RESEARCH APPROACH 36
FIGURE 2 HEARING AIDS MARKET: RESEARCH DESIGN 36
2.2.1 SECONDARY DATA 36
2.2.1.1 Key data from secondary sources 37
2.2.2 PRIMARY DATA 38
2.2.2.1 Primary sources 38
2.2.2.2 Key data from primary sources 39
2.2.2.3 Key industry insights 39
2.2.2.4 Breakdown of primary interviews 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HEARING AIDS MARKET) 40
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 40
2.3 MARKET SIZE ESTIMATION 40
2.3.1 BOTTOM-UP APPROACH 41
2.3.1.1 Approach 1: Company revenue estimation approach 41
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 41
2.3.1.2 Approach 2: Market estimation from the parent market 41
FIGURE 6 BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET 41
2.3.1.3 Approach 3: Presentations of companies and primary interviews 42
2.3.1.4 Growth rate assumptions 42
2.3.1.5 CAGR projections 42
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
?
2.3.2 TOP-DOWN APPROACH 43
FIGURE 8 HEARING AIDS MARKET: TOP-DOWN APPROACH 43
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.5 ASSUMPTIONS FOR THE STUDY 45
2.6 LIMITATIONS 45
2.7 RISK ASSESSMENT 46
TABLE 1 RISKS ASSESSMENT 46
2.8 COVID-19 HEALTH ASSESSMENT 46
2.9 COVID-19 ECONOMIC ASSESSMENT 46
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 47
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE HEARING AIDS MARKET 48
3 EXECUTIVE SUMMARY 49
FIGURE 11 HEARING AIDS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 49
FIGURE 12 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2021 VS. 2026 (USD MILLION) 50
FIGURE 13 HEARING AIDS MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION) 50
FIGURE 14 HEARING AIDS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 51
4 PREMIUM INSIGHTS 52
4.1 HEARING AIDS MARKET OVERVIEW 52
FIGURE 15 RISING PREVALENCE OF HEARING LOSS TO DRIVE THE MARKET GROWTH 52
4.2 HEARING AIDS MARKET SHARE, BY PRODUCT, 2021 VS. 2026 52
FIGURE 16 HEARING AID DEVICES SEGMENT WILL CONTINUE TO DOMINATE
THE MARKET IN 2026 52
4.3 HEARING AIDS MARKET SHARE, BY TYPE OF HEARING LOSS, 2021 VS. 2026 53
FIGURE 17 SENSORINEURAL HEARING LOSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 53
4.4 HEARING AIDS MARKET SHARE, BY PATIENT TYPE, 2021 VS. 2026 53
FIGURE 18 ADULT PATIENTS SEGMENT TO CONTINUE TO DOMINATE
THE MARKET IN 2026 53
4.5 HEARING AIDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE HEARING AIDS MARKET DURING THE FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 20 HEARING AIDS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 55
5.2.1.1 Growing prevalence of hearing loss 55
FIGURE 21 ESTIMATED NUMBER OF PEOPLE WITH DISABLING
HEARING LOSS, GLOBALLY 56
FIGURE 22 PREVALENCE OF HEARING LOSS, BY REGION, 2019 56
5.2.1.1.1 Growth in the geriatric population 57
FIGURE 23 SHARE OF THE GLOBAL POPULATION AGED 65 AND ABOVE (2015–2019) 57
5.2.1.2 Technological advancements in hearing aids 57
5.2.1.3 Increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss 58
5.2.2 RESTRAINTS 58
5.2.2.1 High cost of hearing aids 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Emerging markets offer lucrative opportunities 59
5.2.4 CHALLENGES 59
5.2.4.1 Shortage of trained professionals 59
5.3 EPIDEMIOLOGY DATA ON HEARING LOSS AND THE ADOPTION OF
HEARING AID DEVICES 60
TABLE 2 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020,
BY AGE GROUP 60
TABLE 3 GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020,
BY AGE GROUP (10-YEAR RANGE) 60
TABLE 4 GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP 61
5.4 IMPACT OF COVID-19 ON THE HEARING AIDS MARKET 61
5.5 CASE STUDY ANALYSIS 62
5.5.1 CASE STUDY 1: FINDING A NEW WAY TO LISTEN TO CUSTOMERS 62
5.5.2 CASE STUDY 2: EFFECTIVE SERVICE DELIVERY MODELS AND REGULATIONS CAN IMPROVE ACCESS TO HEARING AIDS 62
5.5.3 CASE STUDY 3: OVER-THE-COUNTER HEARING AID DELIVERY CAN IMPROVE ACCESSIBILITY AND AFFORDABILITY 63
5.6 PESSIMISTIC AND OPTIMISTIC SCENARIOS 63
5.6.1 HEARING AIDS MARKET 63
FIGURE 24 PESSIMISTIC SCENARIO 63
FIGURE 25 OPTIMISTIC SCENARIO 64
5.7 PRICING ANALYSIS 64
TABLE 5 PRICE OF HEARING AIDS (2021) 64
5.8 PATENT ANALYSIS 65
5.8.1 PATENT ANALYSIS OF COCHLEAR IMPLANTS 65
5.9 TRADE ANALYSIS 65
5.9.1 TRADE ANALYSIS FOR HEARING AIDS 65
TABLE 6 IMPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION) 65
TABLE 7 EXPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION) 66
5.10 VALUE CHAIN ANALYSIS 66
FIGURE 26 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE 66
5.10.1 HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR 67
TABLE 8 HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR 67
5.11 SUPPLY CHAIN ANALYSIS 67
FIGURE 27 HEARING AIDS MARKET: SUPPLY CHAIN ANALYSIS 68
5.12 ECOSYSTEM ANALYSIS OF THE HEARING AIDS MARKET 69
FIGURE 28 HEARING AIDS MARKET: ECOSYSTEM ANALYSIS 69
5.12.1 ROLE IN ECOSYSTEM 69
5.13 PORTER’S FIVE FORCES ANALYSIS 70
TABLE 9 HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS 70
5.13.1 THREAT OF NEW ENTRANTS 70
5.13.2 THREAT OF SUBSTITUTES 70
5.13.3 BARGAINING POWER OF BUYERS 70
5.13.4 BARGAINING POWER OF SUPPLIERS 70
5.13.5 DEGREE OF COMPETITION 71
5.14 REGULATORY LANDSCAPE 71
5.14.1 NORTH AMERICA 71
5.14.1.1 US 71
5.14.1.2 Canada 71
5.14.2 EUROPE 71
5.14.3 ASIA PACIFIC 71
5.14.3.1 Japan 71
5.14.3.2 India 72
5.14.4 LATIN AMERICA 72
5.14.4.1 Brazil 72
5.14.4.2 Mexico 72
5.14.5 MIDDLE EAST 72
5.15 TECHNOLOGY ANALYSIS 73
5.16 TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS 74
5.16.1 REVENUE SOURCES ARE SHIFTING TOWARD MORE TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC 74
5.16.2 REVENUE SHIFT FOR THE HEARING AIDS MARKET 74
6 HEARING AIDS MARKET, BY PRODUCT 75
6.1 INTRODUCTION 76
TABLE 10 HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 76
TABLE 11 HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 76
6.2 HEARING AID DEVICES 76
TABLE 12 KEY PRODUCTS IN THE HEARING AID DEVICES MARKET 77
TABLE 13 HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION) 78
TABLE 14 HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (USD MILLION) 78
TABLE 15 HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (MILLION UNITS) 79
TABLE 16 HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (MILLION UNITS) 79
TABLE 17 NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (MILLION UNITS) 80
TABLE 18 NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (MILLION UNITS) 80
TABLE 19 EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (MILLION UNITS) 80
TABLE 20 EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (MILLION UNITS) 81
TABLE 21 APAC: HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (MILLION UNITS) 81
TABLE 22 APAC: HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (MILLION UNITS) 82
TABLE 23 HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION) 82
TABLE 24 HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION) 83
TABLE 25 HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (MILLION UNITS) 83
TABLE 26 HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (MILLION UNITS) 83
6.2.1 RECEIVER-IN-THE-EAR HEARING AIDS 84
6.2.1.1 RITE hearing aid devices are suitable for the treatment of
mild-to-severe hearing loss 84
TABLE 27 KEY PRODUCTS IN THE RECEIVER-IN-THE-EAR HEARING AIDS MARKET 84
TABLE 28 RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION,
2016–2019 (USD MILLION) 85
TABLE 29 RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION,
2020–2026 (USD MILLION) 85
TABLE 30 EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 86
TABLE 31 EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 86
TABLE 32 NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET,
BY COUNTRY, 2016–2019 (USD MILLION) 87
TABLE 33 NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET,
BY COUNTRY, 2020–2026 (USD MILLION) 87
TABLE 34 APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 87
TABLE 35 APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 88
6.2.2 BEHIND-THE-EAR HEARING AIDS 88
6.2.2.1 Low cost of BTE devices to support the market growth 88
TABLE 36 KEY PRODUCTS IN THE BEHIND-THE-EAR HEARING AIDS MARKET 89
TABLE 37 BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION,
2016–2019 (USD MILLION) 89
TABLE 38 BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION,
2020–2026 (USD MILLION) 90
TABLE 39 APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 90
TABLE 40 APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 91
TABLE 41 NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 91
TABLE 42 NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 91
TABLE 43 EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 92
TABLE 44 EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 92
6.2.3 CANAL HEARING AIDS 93
6.2.3.1 Technological advancements in canal hearing aids to
propel market growth 93
TABLE 45 KEY PRODUCTS IN THE CANAL HEARING AIDS MARKET 93
TABLE 46 CANAL HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION) 94
TABLE 47 CANAL HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION) 94
TABLE 48 NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 95
TABLE 49 NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 95
TABLE 50 EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 95
TABLE 51 EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 96
TABLE 52 APAC: CANAL HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 96
TABLE 53 APAC: CANAL HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 96
6.2.4 IN-THE-EAR HEARING AIDS 97
6.2.4.1 Longer battery life of ITE hearing devices to support
the market growth 97
TABLE 54 IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION) 97
TABLE 55 IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION) 97
TABLE 56 EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 98
TABLE 57 EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 98
TABLE 58 APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 99
TABLE 59 APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 99
TABLE 60 NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 99
TABLE 61 NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 100
6.2.5 OTHER HEARING AID DEVICES 100
TABLE 62 OTHER HEARING AID DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION) 100
TABLE 63 OTHER HEARING AID DEVICES MARKET, BY REGION,
2020–2026 (USD MILLION) 101
TABLE 64 EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 101
TABLE 65 EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 102
TABLE 66 NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 102
TABLE 67 NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 102
TABLE 68 APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 103
TABLE 69 APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 103
6.3 HEARING IMPLANTS 103
TABLE 70 HEARING IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION) 104
TABLE 71 HEARING IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION) 104
TABLE 72 EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 104
TABLE 73 EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 105
TABLE 74 NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 105
TABLE 75 NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 105
TABLE 76 APAC: HEARING IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 106
TABLE 77 APAC: HEARING IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 106
TABLE 78 HEARING IMPLANTS MARKET, BY TYPE, 2016–2019 (USD MILLION) 106
TABLE 79 HEARING IMPLANTS MARKET, BY TYPE, 2020–2026 (USD MILLION) 107
6.3.1 COCHLEAR IMPLANTS 107
6.3.1.1 Cochlear implants segment to dominate the hearing implants market 107
TABLE 80 KEY PRODUCTS IN THE COCHLEAR IMPLANTS MARKET 108
TABLE 81 COCHLEAR IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION) 108
TABLE 82 COCHLEAR IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION) 108
TABLE 83 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 109
TABLE 84 EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 109
TABLE 85 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 109
TABLE 86 NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 110
TABLE 87 APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 110
TABLE 88 APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 110
6.3.2 BONE-ANCHORED SYSTEMS 111
6.3.2.1 BAHA implants are gaining traction among children and adults with single-sided deafness and conductive hearing loss 111
TABLE 89 BONE-ANCHORED SYSTEMS MARKET, BY REGION,
2016–2019 (USD MILLION) 111
TABLE 90 BONE-ANCHORED SYSTEMS MARKET, BY REGION,
2020–2026 (USD MILLION) 112
TABLE 91 EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 112
TABLE 92 EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 113
TABLE 93 NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 113
TABLE 94 NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 113
TABLE 95 APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 114
TABLE 96 APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 114
7 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS 115
7.1 INTRODUCTION 116
TABLE 97 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 116
TABLE 98 HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 116
7.2 SENSORINEURAL HEARING LOSS 116
7.2.1 GROWING GERIATRIC PATIENT POOL TO SUPPORT THE GROWTH OF
THIS MARKET SEGMENT 116
7.2.1.1 Primary notes 117
7.2.1.1.1 Key industry insights 117
TABLE 99 HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2016–2019 (USD MILLION) 118
TABLE 100 HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2020–2026 (USD MILLION) 118
7.3 CONDUCTIVE HEARING LOSS 118
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEARING AIDS AND INCREASING PRODUCT APPROVALS TO PROPEL MARKET GROWTH 118
TABLE 101 HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2016–2019 (USD MILLION) 119
TABLE 102 HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2020–2026 (USD MILLION) 119
8 HEARING AIDS MARKET, BY PATIENT TYPE 120
8.1 INTRODUCTION 121
TABLE 103 HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 121
TABLE 104 HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 121
8.2 ADULTS 121
8.2.1 HIGHER SUSCEPTIBILITY TO HEARING LOSS MAKES ADULTS A KEY SEGMENT OF THE OVERALL PATIENT POOL 121
8.2.1.1 Primary notes 122
8.2.1.1.1 Key industry insights 122
TABLE 105 HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION,
2016–2019 (USD MILLION) 123
TABLE 106 HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION,
2020–2026 (USD MILLION) 123
8.3 PEDIATRICS 123
8.3.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF
THIS MARKET SEGMENT 123
TABLE 107 HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2016–2019 (USD MILLION) 124
TABLE 108 HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2020–2026 (USD MILLION) 125
9 HEARING AIDS MARKET, BY REGION 126
9.1 INTRODUCTION 127
TABLE 109 HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION) 127
TABLE 110 HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION) 127
9.2 EUROPE 128
FIGURE 29 EUROPE: HEARING AIDS MARKET SNAPSHOT 128
TABLE 111 EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 129
TABLE 112 EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 129
TABLE 113 EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 129
TABLE 114 EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 130
TABLE 115 EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 130
TABLE 116 EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 130
9.2.1 GERMANY 131
9.2.1.1 Growth in healthcare expenditure in Germany to drive the demand for technologically advanced hearing aids 131
FIGURE 30 PREVALENCE OF HEARING LOSS IN GERMANY, 2015 VS. 2018 131
FIGURE 31 ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN GERMANY, 2012 VS. 2015 VS. 2018 131
TABLE 117 GERMANY: KEY MACROINDICATORS 132
TABLE 118 GERMANY: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 132
TABLE 119 GERMANY: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 133
TABLE 120 GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 133
TABLE 121 GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 133
TABLE 122 GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 134
TABLE 123 GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 134
9.2.2 UK 134
9.2.2.1 High and growing prevalence of hearing loss to drive market
growth in the UK 134
TABLE 124 UK: KEY MACROINDICATORS 135
TABLE 125 UK: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 135
TABLE 126 UK: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 136
TABLE 127 UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 136
TABLE 128 UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 136
TABLE 129 UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 137
TABLE 130 UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 137
9.2.3 FRANCE 137
9.2.3.1 Rising R&D expenditure in France to drive the market growth 137
FIGURE 32 ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN FRANCE, 2012 VS. 2015 VS. 2018 138
TABLE 131 FRANCE: KEY MACROINDICATORS 138
TABLE 132 FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 138
TABLE 133 FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 139
TABLE 134 FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 139
TABLE 135 FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 139
TABLE 136 FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 140
TABLE 137 FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 140
9.2.4 SPAIN 140
9.2.4.1 Increasing life expectancy and growing geriatric population to drive market growth in Spain 140
FIGURE 33 SPAIN: PREVALENCE OF HEARING LOSS IN 2020, BY AGE GROUP 141
TABLE 138 SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 141
TABLE 139 SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 142
TABLE 140 SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 142
TABLE 141 SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 142
TABLE 142 SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 142
TABLE 143 SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 143
9.2.5 ITALY 143
9.2.5.1 Unfavorable reimbursement scenario to restrain market growth in Italy to a certain extent 143
FIGURE 34 PREVALENCE OF HEARING LOSS IN ITALY, 2012 VS. 2015 VS. 2018 143
FIGURE 35 HEARING AIDS ADOPTION RATE IN ITALY, 2012 VS. 2015 VS. 2018 144
TABLE 144 ITALY: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 144
TABLE 145 ITALY: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 144
TABLE 146 ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 145
TABLE 147 ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 145
TABLE 148 ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 145
TABLE 149 ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 146
9.2.6 REST OF EUROPE 146
TABLE 150 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 146
TABLE 151 ROE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 147
TABLE 152 ROE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 147
TABLE 153 ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 147
TABLE 154 ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 148
TABLE 155 ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 148
TABLE 156 ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 148
9.3 NORTH AMERICA 149
TABLE 157 NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION) 149
TABLE 158 NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 149
TABLE 159 NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION) 150
TABLE 160 NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 150
TABLE 161 NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION) 150
TABLE 162 NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION) 151
9.3.1 US 151
9.3.1.1 The US dominated the North American hearing aids market in 2020 151
FIGURE 36 NUMBER OF AUDIOLOGISTS IN THE US 152
TABLE 163 US: KEY MACROINDICATORS 153
TABLE 164 US: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 153
TABLE 165 US: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 153
TABLE 166 US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 154
TABLE 167 US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 154
TABLE 168 US: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION) 154
TABLE 169 US: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION) 155
9.3.2 CANADA 155
9.3.2.1 Conferences, webinars, and symposia to provide impetus to the market growth 155
TABLE 170 CANADA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 156
TABLE 171 CANADA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 156
TABLE 172 CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 156
TABLE 173 CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 157
TABLE 174 CANADA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 157
TABLE 175 CANADA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 157
9.4 ASIA PACIFIC 158
FIGURE 37 ASIA PACIFIC: HEARING AIDS MARKET SNAPSHOT 159
TABLE 176 APAC: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION) 160
TABLE 177 APAC: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 160
TABLE 178 APAC: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 160
TABLE 179 APAC: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 161
TABLE 180 APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 161
TABLE 181 APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 161
9.4.1 CHINA 161
9.4.1.1 China dominated the APAC market for hearing aids in 2020 161
TABLE 182 CHINA: KEY MACROINDICATORS 162
TABLE 183 CHINA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 162
TABLE 184 CHINA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 162
TABLE 185 CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 163
TABLE 186 CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 163
TABLE 187 CHINA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 163
TABLE 188 CHINA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 164
9.4.2 INDIA 164
9.4.2.1 Healthcare infrastructure improvements to drive
market growth in India 164
TABLE 189 INDIA: KEY MACROINDICATORS 165
TABLE 190 INDIA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 165
TABLE 191 INDIA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 165
TABLE 192 INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 166
TABLE 193 INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION) 166
TABLE 194 INDIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION) 166
TABLE 195 INDIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION) 167
9.4.3 JAPAN 167
9.4.3.1 Rising adoption of hearing aids in the country to
support market growth 167
FIGURE 38 HEARING AIDS ADOPTION RATE IN JAPAN, 2012 VS. 2015 VS. 2018 167
TABLE 196 JAPAN: KEY MACROINDICATORS 168
TABLE 197 JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION) 168
TABLE 198 JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 168
TABLE 199 JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION) 169
TABLE 200 JAPAN: HE